The top-performing pharma and biotech stocks as group sees resurgence
Source: SeekingAlpha
2026-02-13 14:01:58 ET
More on pharmaceuticals, biotech
- Big Pharma's Earnings Week: Strong Performance, Obesity Wars, LOE Management And More
- BBH: Mature Biotech Exposure, But Limited Growth Ahead
- XPH: Healthcare Dashboard For January
- Most and least shorted mid-to mega-cap healthcare stocks in January
- FDA opens fast-track program to speed U.S. drug plant construction
Read the full article on Seeking Alpha
For further details see:
The top-performing pharma and biotech stocks as group sees resurgence
ADC Therapeutics SA
NASDAQ: ADCT
ADCT Trading
0.49% G/L:
$4.11 Last:
142,768 Volume:
$4.03 Open:
ADCT Latest News
March 03, 2026 07:15:00 am
ADC Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 10, 2026
February 23, 2026 07:15:00 am
ADC Therapeutics Announces Amended HealthCare Royalty Financing Agreement
ADCT Stock Data
$486,217,661
104,923,913
12.45%
40
N/A
Biotechnology & Life Sciences
Healthcare
CH
Epalinges
